Junya Masumoto Selected Research

Junya Masumoto Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 02/2003
9	Familial Mediterranean Fever (Periodic Disease) 09/2020 - 05/2002
5	Neoplasms (Cancer) 01/2021 - 07/2003
3	Fibrosis (Cirrhosis) 01/2021 - 02/2011
3	Cryopyrin-Associated Periodic Syndromes 11/2020 - 03/2003
3	Fever (Fevers) 09/2020 - 01/2014
2	Adenocarcinoma 11/2021 - 03/2012
2	Infections 10/2021 - 01/2013
2	Tissue Adhesions 01/2021 - 06/2019
2	Blau syndrome 01/2016 - 08/2009
2	Arthritis (Polyarthritis) 01/2014 - 01/2014
2	Carcinoma (Carcinomatosis) 06/2011 - 07/2003
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2021
1	Amyloidosis 01/2021
1	Pain (Aches) 09/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Necrosis 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 11/2015
1	Melanoma (Melanoma, Malignant) 11/2015
1	Systemic Scleroderma (Systemic Sclerosis) 09/2015
1	Osteoarthritis 05/2015
1	Rheumatoid Arthritis 05/2015
1	Osteosarcoma (Osteogenic Sarcoma) 04/2015
1	Hemorrhage 07/2014
1	Gout 01/2014
1	Synovial Sarcoma (Synovioma) 01/2014
1	Immunoglobulin G4-Related Disease 10/2013
1	Lymphadenopathy 10/2013
1	Adenoma (Adenomas) 03/2012
1	Stomach Neoplasms (Stomach Cancer) 03/2012
1	Cholangiocarcinoma 06/2011
1	Infarction (Infarctions) 02/2011
1	Reperfusion Injury 02/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2011
1	Reinjuries 02/2011
1	Hypoxia (Hypoxemia) 02/2011
1	Sarcoma 180 01/2010

Drug/Important Bio-Agent (IBA)

11	InflammasomesIBA 01/2022 - 03/2008
11	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2003
5	CytokinesIBA 01/2021 - 06/2008
5	PyrinIBA 01/2014 - 05/2002
4	Interleukin-1 (Interleukin 1)IBA 01/2019 - 01/2014
4	InterleukinsIBA 01/2016 - 06/2008
3	Interleukin-18 (Interleukin 18)IBA 09/2020 - 06/2008
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2018
2	Pattern Recognition ReceptorsIBA 10/2021 - 11/2015
2	Biological ProductsIBA 10/2021 - 12/2003
2	Biomarkers (Surrogate Marker)IBA 07/2018 - 04/2016
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2014
2	SurvivinIBA 09/2015 - 05/2015
2	Cytotoxins (Cytolysins)IBA 03/2015 - 01/2015
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2014 - 03/2008
2	Interleukin-8 (Interleukin 8)IBA 01/2014 - 08/2006
2	Indicators and Reagents (Reagents)IBA 10/2013 - 07/2007
2	Interleukin-1beta (Interleukin 1 beta)IBA 08/2009 - 06/2008
1	Pathogen-Associated Molecular Pattern MoleculesIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	piperidineIBA 11/2020
1	NucleotidesIBA 09/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2019
1	Hematoxylin (Haematoxylon)IBA 06/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Infliximab (Remicade)FDA Link 07/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2018
1	LipopolysaccharidesIBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Islet Amyloid PolypeptideIBA 01/2018
1	AntibodiesIBA 09/2015
1	Caffeine (No Doz)FDA LinkGeneric 04/2015
1	sorbitan monooleate (Span 80)IBA 04/2015
1	LipidsIBA 07/2014
1	tocilizumab (atlizumab)FDA Link 01/2014
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2014
1	Immunoglobulin G (IgG)IBA 10/2013
1	Type III Secretion SystemsIBA 01/2013
1	Hemolysin Proteins (Hemolysins)IBA 01/2013
1	MucinsIBA 03/2012
1	Polysaccharides (Glycans)IBA 03/2012
1	Gastric MucinsIBA 03/2012
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2011
1	Clathrin Heavy ChainsIBA 06/2011
1	OligopeptidesIBA 06/2011
1	PotassiumIBA 02/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011

Therapy/Procedure

5	Therapeutics 01/2019 - 06/2011
2	Aftercare (After-Treatment) 01/2014 - 03/2008
1	Immunotherapy 01/2021
1	Drug Therapy (Chemotherapy) 04/2015